Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.33 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL526441 | 0.89 | — | — | |
| SCHEMBL9723829 | 0.82 | TSHR (0.38) | KMT2AFAAHTSHRMAPT | |
| SCHEMBL17052579 | 0.81 | FAAH (0.36) | KMT2AFAAHALDH1A1EPHX1GAA | |
| SCHEMBL3627474 | 0.81 | CES2 (0.42) | CES2CES1HDAC8HDAC6ALDH1A1 | |
| SCHEMBL27921007 | 0.80 | TSHR (0.43) | KMT2AFAAHTSHREPHX1ABCC4 | |
| SCHEMBL180345 | 0.79 | CES2 (0.37) | CES2CES1HDAC8HDAC6KMT2A | |
| SCHEMBL7020777 | 0.79 | CES2 (0.37) | CES2CES1HDAC8HDAC6KMT2A | |
| SCHEMBL7020253 | 0.79 | CES2 (0.37) | CES2CES1HDAC8HDAC6KMT2A | |
| SCHEMBL327566 | 0.78 | CES2 (0.44) | CES2CES1HDAC8HDAC6KMT2A | |
| SCHEMBL20755730 | 0.77 | GRM5 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3290085-B1 | HAIR COLOURING OR BLEACHING COMPOSITION WITH REDUCED ODOUR | WELLA OPERATIONS US LLC (US) | 2024-11-06 | — | — | EP | disclosed |
| US-11779530-B2 | Composition for the permanent deformation of hair having reduced odor | WELLA OPERATIONS US, LLC (US) | 2023-10-10 | — | — | US | disclosed |
| US-11771633-B2 | Hair coloring or bleaching composition with reduced odor | WELLA OPERATIONS US, LLC (US) | 2023-10-03 | — | — | US | disclosed |
| US-11696877-B2 | Gel network hair treatment compositions with reduced odor | WELLA OPERATIONS US, LLC (US) | 2023-07-11 | — | — | US | disclosed |
| EP-3290086-B1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOUR | WELLA OPERATIONS US LLC (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-3295925-B2 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | NOXELL CORP (US) | 2022-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11779530-B2 | Composition for the permanent deformation of hair having reduced odor | OR51E2, MAL2, OR10J3 | CES2 2542/4885CES1 2738/4885HDAC8 1438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.